Do US commercial payers consider HTA and economic evidence when making coverage decisions?

That is the question asked in a new paper by Enright, et al. (2025). The authors use the Tufts Medical Center Specialty Drug Evidence and Coverage (SPEC) database current as of August 2023.  This database contains publicly available specialty pharmacy coverage decisions as issued by 18 large US commercial health plans, which—collectively—cover 200m people (i.e.,…

Read More

An Arm and a Leg: A Few Good Things From 2025 (Really)

Massive cuts to medical research and Medicaid. Waves of layoffs across the Department of Health and Human Services. Ongoing uncertainty around federal subsidies to buy health insurance on Affordable Care Act marketplaces. 2025 has been a rough year for federal health programs. But meanwhile, in the states, there were some wins for health care access….

Read More

Indiana Biomedical Society Named Association of the Month

The Indiana Biomedical Society (IBS) was recently recognized as TechNation’s Association of the Month for its commitment to supporting biomedical professionals across the state. Leading the organization is Naka Piohia, Crothall HTS Director at Marion General Hospital, who serves as IBS President. Founded in 1990, IBS provides a platform for professional development, networking, and industry…

Read More

Links

Regulation and Theory of the Adjacent Possible.Alex Taborrok on Trump pharmaceutical plan.Double negotiation? IRA + MFN.Mass General Brigham will provide AI pre-visits.Are ‘mobile crisis’ teams in crisis?

Read More

How does FDA recommend using Bayesian Statistics to inform Regulatory Decisionmaking around clinical trials?

FDA’s January 2026 draft guidance on Bayesian methodology in drug and biologics trials signals a clear willingness to see Bayesian methods used for regulatory decisionmaking around clinical trials. The guidance lays out how sponsors (i.e., pharmaceutical manufacturers) should pre-specify priors, success criteria, and simulations so that Bayesian designs remain interpretable, control error rates when needed,…

Read More

Why Cybersecurity Is Now Central to the Patient Experience

Cybersecurity is no longer a function managed in the IT department’s back office. It’s a front-line brand issue, with real implications for patient satisfaction and loyalty. That means providers need to rethink how they talk about security. It’s no longer enough to be secure; you must communicate security clearly. The post Why Cybersecurity Is Now…

Read More